Beacon Pointe Advisors’s Biotricity, Inc. Common Stock BTCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,635
Closed -$77K 1244
2022
Q1
$77K Buy
+5,635
New +$97.7K ﹤0.01% 1166

Other funds holding BTCY

Beacon Pointe Advisors's BTCY Position: Q2 2022 in Review

Beacon Pointe Advisors sold out of Biotricity, Inc. Common Stock (BTCY) in Q2 2022, closing a stake of 5,635 shares — an estimated $77K sold.

Beacon Pointe Advisors first reported a position in BTCY in Q1 2022 and held it in 1 quarter. The position peaked at $77K in Q1 2022. 27 funds tracked by Wall St. Rank hold BTCY as of Q2 2022.

  • Beacon Pointe Advisors reported no remaining Biotricity, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Beacon Pointe Advisors sold 5,635 Biotricity, Inc. Common Stock shares in Q2 2022, an estimated $77K.
  • Beacon Pointe Advisors first reported a position in Biotricity, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Beacon Pointe Advisors's Biotricity, Inc. Common Stock position peaked at $77K in Q1 2022.
  • 27 funds tracked by Wall St. Rank held Biotricity, Inc. Common Stock as of Q2 2022.

Based on Beacon Pointe Advisors's 13F filing for Q2 2022, filed 11 Aug 2022.